Abstract
Intraductal papillary mucinous neoplasms (IPMNs) characteristically consist of mucin-filled dilated ducts lined with neoplastic cells forming papillae with a diverse range of morphologies and varying grades of atypia. Based on morphological characteristics and immunohistochemical reaction against mucin proteins, IPMNs are classified into four distinct subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. In this chapter, histomorphological criteria and techniques of immunohistochemical staining and its evaluation for subtyping IPMNs are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adsay NV, Fukushima N, Furukawa T, Hruban RH, Klimstra DS, Kloppel G et al (2010) Intraductal neoplasms of the pancreas. In: Bosman FT, Hruban RH, Carneiro F, Theise ND (eds) WHO classification of tumours of the digestive system. WHO classification of tumours, 4th edn. IARC, Lyon, pp 304–313
Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28(8):977–987
Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K et al (1999) Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134(10):1131–1136
Furukawa T, Takahashi T, Kobari M, Matsuno S (1992) The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer 70(6):1505–1513
Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12(3):183–197
Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV et al (2015) A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 39(12):1730–1741
Furukawa T, Kloppel G, Adsay NV, Albores-Saavedra J, Fukushima N, Horii A et al (2005) Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447(5):794–799
Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I et al (1982) Four cases of mucous secreting pancreatic cancer. Prog Digest Endosc 20:348–351
Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH (1996) Histological typing of tumours of the exocrine pancreas. International histological classification of tumours, 2nd edn. Springer-Verlag, Berlin
Yonezawa S, Horinouchi M, Osako M, Kubo M, Takao S, Arimura Y et al (1999) Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol Int 49(1):45–54
Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS (2002) Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 94(1):62–77
Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD et al (2004) Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 28(7):839–848
Adsay NV, Adair CF, Heffess CS, Klimstra DS (1996) Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 20(8):980–994
Abe M, Kufe D (1993) Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. Proc Natl Acad Sci U S A 90(1):282–286
Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DT, Kim YS (1989) Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 264(11):6480–6487
Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ et al (2002) Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123(4):1052–1060
Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS et al (1998) The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol 186(4):398–405
Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N et al (2011) Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 60(4):509–516
Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F et al (2007) Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 34(2):197–204
Hara T, Ikebe D, Odaka A, Sudo K, Nakamura K, Yamamoto H et al (2013) Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain. Ann Surg 257(6):1103–1111
Monzen M, Shimizu K, Hatori T, Furukawa T, Shiratori K (2013) Usefulness of cell block cytology for preoperative grading and typing of intraductal papillary mucinous neoplasms. Pancreatology 13(4):369–378
Kuboki Y, Shimizu K, Hatori T, Yamamoto M, Shibata N, Shiratori K et al (2015) Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas 44(2):227–235
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Furukawa, T. (2019). Subtyping of IPMN. In: Su, G. (eds) Pancreatic Cancer. Methods in Molecular Biology, vol 1882. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8879-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8879-2_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8878-5
Online ISBN: 978-1-4939-8879-2
eBook Packages: Springer Protocols